Channel, Phase Noise, and Frequency Offset in OFDM Systems: Joint Estimation, Data Detection, and Hybrid Cramer-Rao Lower Bound

Oscillator phase noise (PHN) and carrier frequency offset (CFO) can adversely impact the performance of orthogonal frequency division multiplexing (OFDM) systems, since they can result in inter carrier interference and rotation of the signal constellation. In this paper, we propose an expectation conditional maximization (ECM) based algorithm for joint estimation of channel, PHN, and CFO in OFDM systems. We present the signal model for the estimation problem and derive the hybrid Cramer-Rao lower bound (HCRB) for the joint estimation problem. Next, we propose an iterative receiver based on an extended Kalman filter for joint data detection and PHN tracking. Numerical results show that, compared to existing algorithms, the performance of the proposed ECM-based estimator is closer to the derived HCRB and outperforms the existing estimation algorithms at moderate-to-high signal-to-noise ratio (SNR). In addition, the combined estimation algorithm and iterative receiver are more computationally efficient than existing algorithms and result in improved average uncoded and coded bit error rate (BER) performance

Multi-Relay Communications in the Presence of Phase Noise and Carrier Frequency Offsets

Impairments like time varying phase noise (PHN) and carrier frequency offset (CFO) result in loss of synchronization and poor performance of multi-relay communication systems. Joint estimation of these impairments is necessary in order to correctly decode the received signal at the destination. In this paper, we address spectrally-efficient multi-relay transmission scenarios where all the relays simultaneously communicate with the destination. We propose an iterative pilot-aided algorithm based on the expectation conditional maximization (ECM) for joint estimation of multipath channels, Wiener PHNs, and CFOs in decode-and-forward (DF) based multi-relay orthogonal frequency division multiplexing (OFDM) systems. Next, a new expression of the hybrid Cramér-Rao lower bound (HCRB) for the multi-parameter estimation problem is derived. Finally, an iterative receiver based on an extended Kalman filter (EKF) for joint data detection and PHN tracking is employed. Numerical results show that the proposed estimator outperforms existing algorithms and its mean square error performance is close to the derived HCRB at differnt signal-to-noise ratios (SNRs) for different PHN variances. In addition, the combined estimation algorithm and iterative receiver can significantly improve average bit-error rate (BER) performance compared to existing algorithms. In addition, the BER performance of the proposed system is close to the ideal case of perfect channel impulse responses (CIRs), PHNs and CFOs estimation

Channel, Phase Noise, and Frequency Offset in OFDM Systems: Joint Estimation, Data Detection, and Hybrid Cramer-Rao Lower Bound

Oscillator phase noise (PHN) and carrier frequency offset (CFO) can adversely impact the performance of orthogonal frequency division multiplexing (OFDM) systems, since they can result in inter carrier interference and rotation of the signal constellation. In this paper, we propose an expectation conditional maximization (ECM) based algorithm for joint estimation of channel, PHN, and CFO in OFDM systems. We present the signal model for the estimation problem and derive the hybrid Cramer-Rao lower bound (HCRB) for the joint estimation problem. Next, we propose an iterative receiver based on an extended Kalman filter for joint data detection and PHN tracking. Numerical results show that, compared to existing algorithms, the performance of the proposed ECM-based estimator is closer to the derived HCRB and outperforms the existing estimation algorithms at moderate-to-high signal-to-noise ratio (SNR). In addition, the combined estimation algorithm and iterative receiver are more computationally efficient than existing algorithms and result in improved average uncoded and coded bit error rate (BER) performance.ARC Discovery Projects Grant DP14010113

Mechanical and wear properties of aluminum coating prepared by cold spraying

In this study, Al powders were deposited onto Al substrates using cold spray to form a coating. The main objective is to investigate and compare the microstructure, mechanical and wear properties of Al coating to that of the Al substrate. The microstructure of the coating and substrate were observed using Scanning electron microscope (SEM),hardness was evaluated using Vickers hardness test and wear properties were investigated using a pin on disc wear test machine

Risk of Food Poisoning in Canned Foods

The current study aims to examine the danger of food poisoning in canned foods to humans, and the impact of microbes that cause food poisoning on humans. 550 questionnaires were distributed (the target population is residents of the city of Mecca), and responses were obtained from the researcher’s email (from 25-55 years old). In Mecca). Data was collected and analyzed using a table, Excel 2010, pie chart, and graph

The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination

BACKGROUND\ud \ud Sulphadoxine-pyrimethamine (SP) resistance is now widespread throughout east and southern Africa and artemisinin compounds in combination with synthetic drugs (ACT) are recommended as replacement treatments by the World Health Organization (WHO). As well as high cure rates, ACT has been shown to slow the development of resistance to the partner drug in areas of low to moderate transmission. This study looked for evidence of protection of the partner drug in a high transmission African context. The evaluation was part of large combination therapy pilot implementation programme in Tanzania, the Interdisciplinary Monitoring Programme for Antimalarial Combination Therapy (IMPACT-TZ) METHODS: The growth of resistant dhfr in a parasite population where SP Monotherapy was the first-line treatment was measured for four years (2002-2006), and compared with the development of resistant dhfr in a neighbouring population where SP + artesunate (SP+AS) was used as the first-line treatment during the same interval. The effect of the differing treatment regimes on the emergence of resistance was addressed in three ways. First, by looking at the rate of increase in frequency of pre-existing mutant dhfr alleles under monotherapy and combination therapy. Second, by examining whether de-novo mutant alleles emerged under either treatment. Finally, by measuring diversity at three dhfr flanking microsatellite loci upstream of the dhfr gene.\ud \ud RESULTS\ud \ud The reduction in SP selection pressure resulting from the adoption of ACT slowed the rate of increase in the frequency of the triple mutant resistant dhfr allele. Comparing between the two populations, the higher levels of genetic diversity in sequence flanking the dhfr triple mutant allele in the population where the ACT regimen had been used indicates the reduction in SP selection pressure arising from combination therapy.\ud \ud CONCLUSION\ud \ud The study demonstrated that, alleles containing two mutations at the dhfr have arisen at least four times independently while those containing triple mutant dhfr arose only once, and were found carrying a single unique Asian-type flanking sequence, which apparently drives the spread of pyrimethamine resistance associated dhfr alleles in east Africa. SP+AS is not recommended for use in areas where SP cure rates are less than 80% but this study reports an observed principle of combination protection from an area where pyrimethamine resistance was already high

Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine

BACKGROUND\ud \ud It is argued that, the efficacy of anti-malarials could be prolonged through policy-mediated reductions in drug pressure, but gathering evidence of the relationship between policy, treatment practice, drug pressure and the evolution of resistance in the field is challenging. Mathematical models indicate that drug coverage is the primary determinant of drug pressure and the driving force behind the evolution of drug resistance. These models show that where the basis of resistance is multigenic, the effects of selection can be moderated by high recombination rates, which disrupt the associations between co-selected resistance genes.\ud \ud METHODS\ud \ud To test these predictions, dhfr and dhps frequency changes were measured during 2000-2001 while SP was the second-line treatment and contrasted these with changes during 2001-2002 when SP was used for first-line therapy. Annual cross sectional community surveys carried out before, during and after the policy switch in 2001 were used to collect samples. Genetic analysis of SP resistance genes was carried out on 4,950 Plasmodium falciparum infections and the selection pressure under the two policies compared.\ud \ud RESULTS\ud \ud The influence of policy on the parasite reservoir was profound. The frequency of dhfr and dhps resistance alleles did not change significantly while SP was the recommended second-line treatment, but highly significant changes occurred during the subsequent year after the switch to first line SP. The frequency of the triple mutant dhfr (N51I,C59R,S108N) allele (conferring pyrimethamine resistance) increased by 37% - 63% and the frequency of the double A437G, K540E mutant dhps allele (conferring sulphadoxine resistance) increased 200%-300%. A strong association between these unlinked alleles also emerged, confirming that they are co-selected by SP.\ud \ud CONCLUSION\ud \ud The national policy change brought about a shift in treatment practice and the resulting increase in coverage had a substantial impact on drug pressure. The selection applied by first-line use is strong enough to overcome recombination pressure and create significant linkage disequilibrium between the unlinked genetic determinants of pyrimethamine and sulphadoxine resistance, showing that recombination is no barrier to the emergence of resistance to combination treatments when they are used as the first-line malaria therapy

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised